Heidrick & Struggles: How pharma leaders can build necessary digital capabilities
Despite the pharmaceutical sector's substantial technological and scientific capabilities in research and development and the increasing utilization of direct-to-consumer channels, pharmaceutical companies often fall behind other industries when it comes to fully embracing digital advancements.
Pharmaceutical companies have the opportunity to enhance their performance significantly by expediting their digital initiatives, and the guidance and expertise of a Chief Digital Officer (CDO) can be instrumental in achieving success in these specific areas.
Heidrick & Struggles outlines these four opportunities:
- Accelerating traditional R&D
- Implementing personalization
- Making data an asset
- Facilitating faster, more informed decisions